This is a paid advertisement on behalf of FendX Technologies Inc.
Innovative Nanotechnology Repels Even The Strongest Superbugs
FendX’s (FNDX:CSE) award-winning nanotechnology repels viruses and bacteria, including even the strongest superbugs… helping make surfaces safer to touch.
Find out how early investors could benefit from a $3.7 billion market opportunity below.
In the following report, you’ll discover why the growing antimicrobial coating industry – and a company named FendX Technologies Inc. (ticker FNDX on the CSE) – could be a key opportunity for investors…
You’ll see how FendX’s patent-pending non-stick film uses nanotechnology to repel viruses and bacteria…
How its design beat out engineers from over 60 countries and was described as ‘the most innovative invention to have a positive impact on the future’…
And how it could be applied to a variety of different surfaces, offering instant protection against the spread of pathogens.
Listen, as we’ve experienced over the past few years, the rampant spread of pathogens is one of society’s most challenging problems.
FendX’s solution repels microbes and helps prevent their spread at the nano-level.
It could be a key weapon to contribute in the battle against the growing global threat of infectious disease transmission.
And you have the opportunity to position yourself in FendX’s future today – at an early stage – before the company’s initial scale-up manufacturing tests put it on the potential path to commercialization (assuming tests are successful).
One of the Greatest Threats Facing Humanity
The spread of infectious disease is a deadly problem that’s only getting worse…
As the world population grows, population centers are becoming denser. That means people are living closer together than ever before – and more likely to spread germs through common surfaces you touch such as handrails and door handles.
What’s worse, the overuse and misuse of antibiotics have led to the emergence of antibiotic-resistant bacteria, or “superbugs”. These treatment-resistant microbes are becoming more common and more dangerous.
- In fact, the National Health Institute calls antimicrobial resistance a “Global Health Emergency”.
- UK health officials recently warned, “antimicrobial resistance was a “hidden pandemic” that could emerge in the wake of Covid-19…
- And the World Health Organization calls antimicrobial resistance one of the top 10 global public health threats facing humanity – right up there with Ebola, HIV, and noncommunicable diseases such as diabetes, cancer and heart disease.
What’s worse, many treatment-resistant superbugs are spread inside of what’s thought to be a safe environment: hospitals, long-term care facilities, and senior’s homes.
In fact, the CDC estimates on any given day, a shocking 1-in-31 hospital patients acquire a hospital-borne infection (i.e. an infection acquired while being treated in a medical facility).
The direct medical costs associated with these infections are massive, totaling at least $28.4 billion each year. They also account for an additional $12.4 billion in costs to society from early deaths and lost productivity.
And with new virus strains emerging and increasing antibiotic resistant bacteria, there’s a growing demand for innovative solutions to protect against their spread.
In fact, research firm Future Markets Inc. projects the antimicrobial coatings market size will hit $11.0 billion by 2027, almost tripling in a five-year span.
FendX’s proprietary nanotechnology has repelling properties that prevent adhesion of bacteria, viruses and liquids.
Inspired by water-resistant lotus leaves, the technology consists of nanoscopic wrinkles 1,000 times smaller than a human hair. These wrinkles create a nanostructure surface which liquids, blood, bacteria, viruses – almost anything – essentially can’t stick to.
The technology was originally discovered by scientists at the famed McMaster University. It’s been detailed in several academic journals, including the prestigious ACS Nano. And it’s backed by a growing pending patent portfolio.
It’s also been featured on major news and media outlets such as CNN Health, CBC, and Science Daily:
- CNN Health says, “Researchers have developed a self-cleaning plastic wrap that repels bacteria and could be used to prevent the transfer of antibiotic resistant superbugs, and other forms of dangerous bacteria.” 
- CBC says, “Scientists engineer self-cleaning surface that can repel dangerous bacteria”
- And Science Daily reports it’s a “self-cleaning surface that repels even the deadliest superbugs.”
Now, to be clear, this technology is still in the development testing phase. Lab tests at McMaster have been successful, and lab prototypes have been produced. But it’s not yet available on the market however – there’s still work to be done.
But think of the potential if it’s successful…
We’re talking about a technology that could be deployed all over the world.
It could make life safer for you, your children, the elderly and millions of others.
And as an investor, it commands your immediate attention.
How FendX (FNDX:CSE) Could Be Part of a $3.7 Billion Market
Viruses and bacteria are all around us… on door handles, grocery carts, store checkout stations, payment machines, bathroom sinks/taps, railings, elevator buttons and more.
They cling, grow and thrive on everyday surfaces like glass, paper, and metal. And they can survive for days… weeks… even months unless disinfected.
In fact, studies have shown that:
- The influenza virus can survive for up to 17 days on things like banknotes…
- Some bacteria – including deadly E. Coli and MRSA – can survive for months on inanimate surfaces.
- And the COVID-19 causing SARS-CoV-2 virus can survive for 28 days on glass, paper, and steel.
- Reduces the amount of infectious viral particles for Covid-19 related strains by more than 99%…
- Reduces the transfer of E-coli 20-fold…
- And it reduces the formation of bacterial colonies like MRSA and pneumonia-causing Pseudomonas aeruginosa by more than 85%. 
Here’s How REPELWRAP™ Works:
In fact, the repel rates against potentially deadly pathogens are impressive:
- Reduces the amount of infectious viral particles for Covid-19 related strains by more than 99%…
- Reduces the transfer of E-coli 20-fold…
- And it reduces the formation of bacterial colonies like MRSA and pneumonia-causing Pseudomonas aeruginosa by more than 85%. 
Because of the unique “repel” ability, REPELWRAP™ film attacks the problem of pathogen spread much differently than anything else on the market today.
One of the biggest differences is that other protective coating films require viruses and bacteria to attach to their surface. Pathogens that attach to these surfaces have the potential to be passed on to unsuspecting individuals when they touch it.
For example, some competitors’ films contain silver or copper that can kill pathogens. But these products require pathogens to stick to their surface first before they can be killed… and that process can take up to a few hours to effectively kill all viruses or bacteria.
This creates a “window of transmission” where contaminated surfaces can spread infections – especially in high-traffic touch point areas.
What’s worse, these metal containing surfaces can lead to bacterial resistance – making the problem of superbugs even worse.
In contrast, FendX’s REPELWRAP™ film uses nano-scale engineering to create a surface that pathogens can’t attach to. Since pathogens can’t attach, they can’t replicate and create colonies to be passed on.
This means that if a REPELWRAP™-coated surface is touched with a contaminated hand, there is smaller chance for this contamination to spread.
Another major benefit of FendX’s nanotechnology is that it’s flexible.
It can be applied to flat surfaces or shrunk wrapped onto surfaces that aren’t.
From curved door handles to twisting handrails to flat countertops, REPELWRAP™ film is expected to be able to fully coat an object to provide maximum protection.
FendX’s REPELWRAP™ Film has Many Advantages:
- It significantly reduces the transfer of deadly pathogens like MRSA, E-Coli, COVID-19 related viruses…
- It works instantly…
- It’s flexible to cover many different surface types…
- And it offers 24-7 protection.
As an investor, you need to pay close attention to FendX (FNDX:CSE).
The company’s nanotechnology could be part of the answer for businesses and governments looking to mitigate the spread of pathogens.
The Market Potential For FendX Could be Enormous…
Future Markets Inc. estimates the antimicrobial coatings market size will triple in size to $11.0 billion in 2027, up from $3.7 billion in 2022.
FendX has the potential to become a major player in the antimicrobial film market (should REPELWRAP™ film successfully be scaled-up to larger sizes films and be successful in commercial scale-up manufacturing).
When commercialized, it could address the urgent need for innovative solutions to help control the spread of pathogens on surfaces – especially in healthcare.
As mentioned earlier, approximately 1-in-31 hospital patients get a healthcare-associated infection. That’s a huge number of people being exposed to harmful pathogens in what’s “supposed” to be considered a safe environment.
These pathogens can also be life-threatening for vulnerable and compromised persons.
- In fact, the World Health Organization claims that 1 in 10 patients who get a healthcare-associated infection will die… while Oxford Academic estimates these infections are the fourth leading cause of death in the United States.
It’s staggering and scary. But what’s worse is this…
Contaminated surfaces and equipment are some of the most common causes of infection according to the National Health Institute. 
It finds that contact transmission – when an infected patient comes in direct contact with another or contaminates a surface like a doorknob – is the one of the most important and frequent mode of transmission in the health care setting.
FendX’s proprietary REPELWRAP™ film could be used on high-touch surfaces such as bed rails, doorknobs, and medical devices to help prevent pathogen transmission.
As FendX continues its product development, we may see it used to protect surfaces in other high traffic places like the transportation, sports and entertainment, hospitality, and education sectors.
Take public transport for instance.
Millions of people use public transportation everyday – touching railings, handles and more. But how often do you see them being sanitized?
Then there’s education centers like schools and universities.
There are over 200,000 primary and secondary schools in North America, Europe, and Japan.  
Protecting high touch point areas such as desks and door handles, and preventing the transmission of pathogens in the education system could be a key focus in reducing spread.
And let’s not forget public places like stadiums, malls, restaurants and entertainment centers…
Preventing the transfer of pathogens in public settings is important to control the spread of disease… and keeping surfaces clean in these sectors is not always possible.
But, as mentioned above, the company does not yet have a commercial product…
The nanotechnology was licensed from McMaster University and the REPELWRAP™ film prototype has been tested successfully in in their labs. The next step is to create larger-sized prototypes of its REPELWRAP™ film for testing.
To do that, FendX has partnered with engineering experts Dunmore International, Corp., a Steel Partners Holdings L.P. (NYSE:SPLP) company.
The engagement of the Dunmore team is the first step on its path towards commercialization and an important milestone for the company.
Dunmore will use their expertise to assess and create an initial automated manufacturing process for larger-sized prototypes for testing. If successful, it will position FendX to potentially begin commercial scale-up.
FendX’s patent-pending technology has the potential to tap a big opportunity in helping work towards solving the global threat of infectious disease transmission.
There are several multi-billion-dollar industries in need of innovative products to control the spread of pathogens. REPELWRAP™ film may have the potential to play a role in many of these industries.
Do your own research now.
Microbe repellent technology is a promising, high-growth industry. And FendX is positioning itself to take advantage of this opportunity.
Given the increasing demand for innovative products to reduce the spread of pathogens in various industries…
The heightened awareness of pathogen transmission…
And the growing number of healthcare-acquired infections…
Nanotechnology with Repelling Properties:
FendX’s nanotechnology is inspired by water-resistant lotus leaves and consists of nanoscopic wrinkles 1,000 times smaller than a human hair.
These wrinkles create a nanostructure which liquids, blood, bacteria, viruses – almost anything – can’t stick to. It works instantly and offers 24-7 protection, addressing the growing need for new products to contribute to continuous protection of surfaces prone to contamination to reduce the spread of pathogens.
Multi-Billion-Dollar Market Potential:
Global infections continue to rise despite efforts to contain the spread. This is increasing the demand for innovative and effective infection control measures.
FendX has the potential to be adopted across various high-traffic public settings such as healthcare facilities, public transportation, schools, and offices. The sheer size and diversity of the target market has the potential to present a large future growth opportunity.
Timely and Relevant:
In an era where public health and safety concerns are at an all-time high, FendX may address the needs and worries of consumers and businesses alike, potentially making it an attractive and relevant opportunity.
Different From Other Antimicrobial Coating Films:
FendX’s pathogen-repelling technology is different than other films on the market today.
Other films require viruses and bacteria to attach to their surface to be killed, creating a potential “window of transmission” where bacteria or viruses on the film can still be spread.
FendX uses nanoscale engineering to create surfaces that pathogens can’t attach to. Since pathogens can’t attach, they’re hard to pass them on.
Future, Untapped Markets Add Potential:
FendX’s nanotechnology has the potential to be applied to other types of surfaces and materials – such as catheters which could significantly help reduce blockages caused by bacterial colony and/or blood clot formation in long-use catheters.
Underserved markets like this offer potential future upside, if the company can successfully adapt their technology.
Talk to your broker today.
Email: [email protected]
This article is a paid advertisement. ARU Global Inc. and its owners, managers, employees, and assigns (collectively “the Publisher”) is often paid by profiled companies or third parties to organize marketing campaigns, which include the creation and dissemination of these types of communications. In this case, in an effort to enhance public awareness of FendX Technologies Inc. (“FNDX”) and its securities, FNDX has provided the Publisher with a budget of approximately $500,000.00 USD to cover the costs associated with creating and distribution of this communication. The Publisher may retain any excess sums after expenses as its compensation. This compensation should be viewed as a major conflict with our ability to be unbiased. Readers should beware that third parties, profiled companies, and/or their affiliates may liquidate shares of the profiled companies at any time, including at or near the time you receive this communication, which has the potential to hurt share prices. Frequently companies profiled in our articles experience a large increase in volume and share price during the course of investor awareness marketing, which often ends as soon as the investor awareness marketing ceases. The investor awareness marketing may be as brief as one day, after which a large decrease in volume and share price may likely occur. This communication is not, and should not be construed to be, an offer to sell or a solicitation of an offer to buy any security. Neither this communication nor the Publisher purport to provide a complete analysis of any company or its financial position. The Publisher is not, and does not purport to be, a broker-dealer or registered investment adviser. This communication is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about the company. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the advertised company’s SEC, SEDAR and/or other government filings. Investing in securities, particularly microcap securities, is speculative and carries a high degree of risk. Past performance does not guarantee future results. This communication is based on information generally available to the public and on interviews with company management, and does not (to the Publisher’s knowledge, as confirmed by FNDX) contain any material, non-public information. The information on which it is based is believed to be reliable. Nevertheless, the Publisher cannot guarantee the accuracy or completeness of the information.
SHARE OWNERSHIP. The owner of ARU Global Inc. may be buying and selling shares of this issuer for its own profit. The Publisher has no information concerning share ownership by others in the profiled company FNDX. The Publisher cautions readers to beware that third parties, profiled companies, and/or their affiliates may liquidate shares of the profiled companies at any time, including at or near the time you read the articles on this website and this has the potential to hurt share prices. Frequently companies profiled in such articles experience a large increase in volume and share price during the course of investor awareness marketing, which often ends as soon as the investor awareness marketing ceases. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities.
This article contains certain forward-looking statements within the meaning of Canadian securities legislation (the “Forward-looking Statements”), including with respect to: the plans of FNDX; expectations regarding industry trends, including with respect to the antimicrobial surface market, overall market growth rates and FNDX’s growth rates and growth strategies; that microbe repellent technology is a promising, high-growth industry; the use of available funds; the performance of FNDX’s business and operations; FNDX’s expectations regarding revenues, expenses and anticipated cash needs; the intention to grow FNDX’s business and operations; the expected timing and completion of FNDX’s near‑term objectives; laws and regulations and any amendments thereto applicable to FNDX; FNDX’s competitive advantages and business strategies; FNDX’s future product offerings; FNDX’s research and development initiatives and expected results thereof; FNDX’s growing patent portfolio; FNDX’s ability to enter into distribution, manufacturing and other business relationships; the potential of FNDX’s technology to protect against the spread of pathogens on surfaces through repelling bacteria and viruses that come in contact with its surface; that FNDX’s technology will bring significant value in controlling the spread of surface borne infectious diseases; that FNDX’s technology could be a key weapon to contribute in the battle against the growing global threat of infectious disease transmission; that FNDX’s technology could be deployed all over the world and it could save human lives; that spread of infectious disease is a deadly problem which is getting worse; that for businesses and governments looking to mitigate the spread of pathogens, FNDX’s nanotechnology could be part of the answer; if commercialized, FNDX’s technology could address the urgent need for innovative solutions to help control the spread of pathogens on surfaces – especially in healthcare; FNDX’s proprietary REPELWRAP™ film could be used on high-touch surfaces such as bed rails, doorknobs, and medical devices to help prevent pathogen transmission; FNDX’s nanotechnology has the potential to be applied to other types of surfaces and materials – such as catheters which could significantly help reduce blockages caused by bacterial colony and/or blood clot formation in long-use catheters and that underserved markets like this offer potentially future upside, if FNDX can successfully adapt their technology; FNDX’s intention to initially target REPELWRAPTM film towards healthcare settings and high traffic public touchpoints; that as FNDX continues its product development, we may see it used to protect surfaces in other high traffic places like the transportation, sports and entertainment, hospitality, and education sectors; the growing global commitment to reduce the spread of pathogens; and that REPELWRAP™ film will provide additional protection to current disinfecting practices to control the spread of pathogens. Although FNDX believes that such statements are reasonable, it can give no assurance that such expectations will prove to be correct. Forward-looking statements are statements that are not historical facts; they are generally, but not always, identified by the words “expects,” “plans,” “anticipates,” “believes,” “intends,” “estimates,” “projects,” “aims,” “potential,” “goal,” “objective,” “prospective,” and similar expressions, or that events or conditions “will,” “would,” “may,” “can,” “could” or “should” occur, or are those statements, which, by their nature, refer to future events. FNDX cautions that forward-looking statements are based on the beliefs, estimates and opinions of FNDX’s management on the date the statements are made and they involve a number of risks and uncertainties. Consequently, there can be no assurances that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements.
Important factors that could cause future results to differ materially from those anticipated in these forward-looking statements include: product candidates only being in formulation/reformulation stages; limited operating history, no revenues and uncertainty around additional financing; negative cash flow history; no production history and lack of revenues from sales; no history of manufacturing or distribution; highly competitive industry; satisfying the terms of the License Agreement and Collaborative Research Agreement between FNDX and McMaster University and maintaining the License in good standing; inability of McMaster University to satisfy the terms under the License Agreement and Collaborative Research Agreement; completion of scale-up and development of a commercial product; research and development activities; reliance on grant funding; limited number of products; dependence on collaborative partners, licensors and others; changes and restrictions due to legal and regulatory requirements; dependence on each product’s acceptance in the market; possibility of smaller market opportunities than anticipated; increasing regulatory and compliance costs for public companies; global economic instability; product liability claims and lawsuits; system failures; reliance on management and loss of key employees or inability to hire key personnel; limited experience of senior management in managing a public company; fraudulent or illegal activity by employees, contractors and consultants; inability to effect service of process on some of FNDX’s directors and officers; management’s efforts and abilities; potential conflicts of interest; inability to protect intellectual property rights; inability to secure patents or grow its patent portfolio; infringement on proprietary rights of third parties; risks related to forward-looking information; volatility of the market price of FNDX’s common shares; potential dilution of the common shares; lack of an active, liquid and orderly trading market for the common shares; failure of securities or industry analysts to publish research or publish inaccurate or unfavourable research about FNDX; inability or unwillingness to pay dividends; exchange rate fluctuations between the Canadian dollar and the U.S. dollar; effect of COVID-19 public health crisis or another global health pandemic; use of available funds; effect of general economic and political conditions; internal controls; and other risk factors set forth in FNDX’s final prospectus dated January 31, 2023 under the heading “Risk Factors” and other filings, publicly available through the Canadian Securities Administrators’ System for Electronic Document Analysis and Retrieval (SEDAR) at www.sedar.com. The reader is urged to refer to FNDX’s prospectus and other filings, publicly available through SEDAR at www.sedar.com for a more complete discussion of such risk factors and their potential effects. Except to the extent required by applicable securities laws and the policies of the Canadian Securities Exchange, FNDX undertakes no obligation to update these forward-looking statements if management’s beliefs, estimates or opinions, or other factors, should change. New factors emerge from time to time, and it is not possible for FNDX to predict all of them or assess the impact of each such factor or the extent to which any factor, or combination of factors, may cause results to differ materially from those contained in any Forward-looking Statement. Any Forward-looking Statements contained in this article are expressly qualified in their entirety by this cautionary statement.
While the information contained in this article is believed to be accurate, FNDX expressly disclaims any and all liability for any losses, claims or damages of whatsoever kind based upon the information contained in, or omissions from, this article or any oral communication transmitted in connection therewith. In addition, none of the statements contained in this article are intended to be, nor shall be deemed to be, representations or warranties of FNDX. Where the information is from third-party sources, the information is from sources believed to be reliable, but FNDX has not independently verified any of such information contained herein.
This article is not, and under no circumstances is to be construed as, a prospectus, an offering memorandum, an advertisement or a public offering of securities. Under no circumstances should the information contained herein be considered an offer to sell or a solicitation of an offer to buy any securities.
IMPORTANT NOTICE AND DISCLAIMER
This website is owned and hosted by Market Tactic Media Ltd. Articles appearing on this website should be considered paid advertisements. Market Tactic Media Ltd. and its owners, managers, employees, and assigns (collectively “the Website Host”) is often paid by marketing companies to host websites on which articles profiling public companies are published. The Website Host has not been compensated by any of the profiled companies. The Website Host’s compensation for articles appearing on this website is as follows:
- The Website Host has been paid approximately $500 per week while the advertisement campaign is active by Think Ink Marketing as compensation to host the article profiling FendX Technologies Inc.
The Website Host does not own any shares of any profiled FendX Technologies Inc. and has no information concerning share ownership by others of any profiled companies and The Website Host cautions readers to beware that third parties, profiled companies, and/or their affiliates may liquidate shares of the profiled companies at any time, including at or near the time you read the articles on this website and this has the potential to hurt share prices. Frequently companies profiled in such articles experience a large increase in volume and share price during the course of investor awareness marketing, which often ends as soon as the investor awareness marketing ceases.
NO SECURITIES OFFERED
The articles on this website are not, and should not be construed to be, offers to sell or solicitations of an offer to buy any security. Neither the articles on this website nor the Website Host purport to provide a complete analysis of any FendX Technologies Inc. or its financial position. The Website Host is not, and does not purport to be, a broker-dealer or registered investment adviser. The articles on this website are not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about the FendX Technologies Inc.. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the profiled FendX Technologies Inc.’s SEC and/or other government filings. Investing in securities, particularly microcap securities, is speculative and carries a high degree of risk.
INDEMNIFICATION/RELEASE OF LIABILITY
By reading articles on this website, you acknowledge that you have read and understood this disclaimer, and further that to the greatest extent permitted under law, you release the Website Host, its affiliates, assigns and successors from any and all liability, damages, and injury from articles appearing on this website. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.
LINKS TO THIRD PARTY WEBSITES
This website enables users to link to external websites not under the control of The Website Host. The Website Host has no control over the nature, content, and availability of those sites. The inclusion of any links is not intended as, and should not be construed as, a recommendation or endorsement of the content or views expressed on such external websites. The Website Host expressly disclaims any representation concerning the quality, safety, suitability, or reliability of any external websites and the content and materials contained in them. It is important for users to take necessary precautions, especially to ensure appropriate safety.
The Market Tactic is the Website Host’s trademark. All other trademarks used in this communication are the property of their respective trademark holders. The Website Host is not affiliated, connected, or associated with, and is not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made by the Website Host to any rights in any third-party trademarks.
FORWARD LOOKING INFORMATION
This document contains forward-looking information and forward-looking statements, within the meaning of applicable Canadian securities legislation, (collectively, “forward-looking statements”), which reflect expectations regarding FendX Technologies Inc. future growth, future business plans and opportunities, expected activities, and other statements about future events, results or performance. Wherever possible, words such as “predicts”, “projects”, “targets”, “plans”, “expects”, “does not expect”, “budget”, “scheduled”, “estimates”, “forecasts”, “anticipate” or “does not anticipate”, “believe”, “intend” and similar expressions or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or the negative or grammatical variation thereof or other variations thereof, or comparable terminology have been used to identify forward-looking statements. These forward-looking statements include, among other things, statements relating to: (a) revenue generating potential with respect to FendX Technologies Inc. industry; (b) market opportunity; (c) FendX Technologies Inc. business plans and strategies; (d) services that FendX Technologies Inc. intends to offer; (e) FendX Technologies Inc. milestone projections and targets; (f) FendX Technologies Inc. expectations regarding receipt of approval for regulatory applications; (g) FendX Technologies Inc. intentions to expand into other jurisdictions including the timeline expectations relating to those expansion plans; and (h) FendX Technologies Inc. expectations with regarding its ability to deliver shareholder value. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, as of the date of this document including, without limitation, assumptions about: (a) the ability to raise any necessary additional capital on reasonable terms to execute FendX Technologies Inc. business plan; (b) that general business and economic conditions will not change in a material adverse manner; (c) FendX Technologies Inc. ability to procure equipment and operating supplies in sufficient quantities and on a timely basis; (d) FendX Technologies Inc. ability to enter into contractual arrangements; (e) the accuracy of budgeted costs and expenditures; (f) FendX Technologies Inc. ability to attract and retain skilled personnel; (g) political and regulatory stability; (h) the receipt of governmental, regulatory and third-party approvals, licenses and permits on favorable terms; (i) changes in applicable legislation; (j) stability in financial and capital markets; and (k) expectations regarding the level of disruption as a result of COVID-19. Such forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of FendX Technologies Inc. to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: (a) FendX Technologies Inc. operations could be adversely affected by possible future government legislation, policies and controls or by changes in applicable laws and regulations; (b) public health crises such as the COVID-19 pandemic may adversely impact FendX Technologies Inc. business; (c) the volatility of global capital markets; (d) political instability and changes to the regulations governing FendX Technologies Inc. business operations (e) FendX Technologies Inc. may be unable to implement its growth strategy; and (f) increased competition. Except as required by law, the Website Host undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise.
Any graphs, tables or other information demonstrating the historical performance or current or historical attributes of FendX Technologies Inc. or any other entity contained in this document are intended only to illustrate historical performance or current or historical attributes of FendX Technologies Inc. or such entities and are not necessarily indicative of future performance of FendX Technologies Inc. or such entities.
 Future Markets Inc., January 2023
 Future Markets Inc., January 2023